Literature DB >> 19276353

GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.

Gaurisankar Sa1, Tanya Das, Christina Moon, Cynthia M Hilston, Patricia A Rayman, Brian I Rini, Charles S Tannenbaum, James H Finke.   

Abstract

We previously elucidated an important role for gangliosides in renal cell carcinoma-mediated T lymphocyte apoptosis, although the mechanism by which they mediated lymphocyte death remained unclear. Here, we show that when added in purified form, GD3 is internalized by activated T cells, initiating a series of proapoptotic events, including the induction of reactive oxygen species (ROS), an enhancement of p53 and Bax accumulation, an increase in mitochondrial permeability, cytochrome c release, and the activation of caspase-9. GD3-induced apoptosis of activated T cells was dose dependent and inhibitable by pretreating the lymphocytes with N-acetylcysteine, cyclosporin A, or bongkrekic acid, emphasizing the essential role of ROS and mitochondrial permeability to the process. Ganglioside-induced T-cell killing was associated with the caspase-dependent degradation of nuclear factor-kappaB-inducible, antiapoptotic proteins, including RelA; this suggests that their loss is initiated only after the cascade is activated and that their disappearance amplifies but not triggers GD3 susceptibility. Resting T cells did not internalize appreciable levels of GD3 and did not undergo any of the proapoptotic changes that characterize activated T lymphocytes exposed to the ganglioside. RelA overexpression endows Jurkat cells with resistance to GD3-mediated apoptosis, verifying the role of the intact transcription factor in mediating protection from the ganglioside.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276353      PMCID: PMC2728031          DOI: 10.1158/0008-5472.CAN-08-3776

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

2.  GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion.

Authors:  M R Rippo; F Malisan; L Ravagnan; B Tomassini; I Condo; P Costantini; S A Susin; A Rufini; M Todaro; G Kroemer; R Testi
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

3.  Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.

Authors:  J H Finke; P Rayman; R George; C S Tannenbaum; V Kolenko; R Uzzo; A C Novick; R M Bukowski
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

4.  Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.

Authors:  G V Shurin; M R Shurin; S Bykovskaia; J Shogan; M T Lotze; E M Barksdale
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

5.  Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation.

Authors:  C García-Ruiz; A Colell; R París; J C Fernández-Checa
Journal:  FASEB J       Date:  2000-05       Impact factor: 5.191

6.  Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma.

Authors:  A C Bharti; S M Singh
Journal:  Immunol Lett       Date:  2000-04-03       Impact factor: 3.685

7.  GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells.

Authors:  Anil Kumar Bhunia; Gunter Schwarzmann; Subroto Chatterjee
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

8.  Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

Authors:  Amit Choudhury; Michel Dominguez; Vishwajeet Puri; Deepak K Sharma; Keishi Narita; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha.

Authors:  Carmen García-Ruiz; Anna Colell; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Biol Chem       Date:  2002-07-12       Impact factor: 5.157

Review 10.  Genetics and epigenetics of renal cell cancer.

Authors:  Marcella M L Baldewijns; Iris J H van Vlodrop; Leo J Schouten; Patricia M M B Soetekouw; Adriaan P de Bruïne; Manon van Engeland
Journal:  Biochim Biophys Acta       Date:  2007-12-15
View more
  34 in total

Review 1.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

2.  Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

Authors:  Gouri Sankar Sen; Suchismita Mohanty; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Shuvomoy Banerjee; Juni Chakraborty; Shilpi Saha; Pallab Ray; Pushpak Bhattacharjee; Debaprasad Mandal; Arindam Bhattacharya; Samit Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

3.  Programmed death-1 controls T cell survival by regulating oxidative metabolism.

Authors:  Victor Tkachev; Stefanie Goodell; Anthony W Opipari; Ling-Yang Hao; Luigi Franchi; Gary D Glick; James L M Ferrara; Craig A Byersdorfer
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

Review 4.  Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.

Authors:  Magis Mandapathil; Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2011-06-26       Impact factor: 4.388

Review 5.  Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Authors:  Annie A Wu; Virginia Drake; Huai-Shiuan Huang; ShihChi Chiu; Lei Zheng
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

6.  Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Authors:  Gautam N Shenoy; Jenni Loyall; Charles S Berenson; Raymond J Kelleher; Vandana Iyer; Sathy V Balu-Iyer; Kunle Odunsi; Richard B Bankert
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

7.  Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.

Authors:  Suzanne M Birks; John Owusu Danquah; Linda King; Reinhardt Vlasak; Dariusz C Gorecki; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2011-07-31       Impact factor: 12.300

Review 8.  The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).

Authors:  T L Whiteside; M Mandapathil; P Schuler
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 9.  Multifocal signal modulation therapy of cancer: ancient weapon, modern targets.

Authors:  Tanya Das; Gaurisankar Sa; Baisakhi Saha; Kaushik Das
Journal:  Mol Cell Biochem       Date:  2009-10-14       Impact factor: 3.396

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.